Connection
Jill Slansky to Cytotoxicity, Immunologic
This is a "connection" page, showing publications Jill Slansky has written about Cytotoxicity, Immunologic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.222 |
|
|
|
-
Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE. Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proc Natl Acad Sci U S A. 2010 Mar 09; 107(10):4652-7.
Score: 0.084
-
McMahan RH, Slansky JE. Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol. 2007 Aug; 17(4):317-29.
Score: 0.070
-
Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity. 2000 Oct; 13(4):529-38.
Score: 0.044
-
Mitchell L, Dow SW, Slansky JE, Biller BJ. Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma. Vet Immunol Immunopathol. 2012 Feb 15; 145(3-4):597-603.
Score: 0.024